News | Vascular Access | September 20, 2016

Teleflex Promotes Rise of the Vascular Access Specialist at AVA 2016 Congress

Company features new online clinical education platform, hosts several symposia on vascular access technology

Teleflex, AVA 2016 Congress, Association for Vascular Access

September 20, 2016 — Teleflex Inc. recently displayed its vascular access technologies and a new educational platform focused on the rise of the vascular access specialist at the 30th Annual Scientific Meeting of the Association for Vascular Access (AVA). The meeting was held Sept. 16-19 in Orlando, Fla.

Teleflex unveiled the Teleflex Academy, a new online clinical education platform. The booth educational experience for the Teleflex Academy at this year’s AVA focused on every aspect of vascular access. Teleflex believes that quality education is the first step in fostering the expansion of skills and helping to shape clinical practice.

Teleflex also launched the Arrow Midline with Chlorag+ard Technology, adding to the family of antithrombogenic and antimicrobial protected catheters.

The company offered its popular Vascular Access Procedural Cadaver Lab onsite, training on many different vascular access procedures. There were also clinical education activities at its booth, where models were used to demonstrate the full range of the company’s vascular access devices.

At the breakfast symposium, “Rising to the Challenge: How Vascular Access Specialists Started Placing CVCs,” attendees were educated on the importance of the evolution of the vascular access specialist. This course highlighted the experiences of clinicians who have made the journey to expand their roles to place central venous catheters, and described the clinical process and materials needed to develop a vascular access team.

The platinum showcase symposium, “Locking the Lumen…Consider the Solutions!” reviewed why given today’s medical reimbursement risks, facilities must explore all opportunities to reduce potential vascular access complications. Locking solutions could provide an additional layer of protection when used in conjunction with proven protected catheter technology. The presentation addressed catheter colonization, intraluminal colonization, and how locking solutions and protected catheters address these.

The dinner symposium, “Strategy or Risk: the Use of Midline Catheters”, focused on the recent popularity of Midline catheters, the role of a Midline, and how technology could be the key to ensuring Midline success.

For more information: www.teleflex.com

Related Content

Shockwave Announces Collaboration With Abiomed on Physician Training
News | Cath Lab | December 14, 2018
Shockwave Medical announced a new investment and collaboration agreement with Abiomed Inc. As outlined by the agreement...
Sponsored Content | Videos | Cath Lab | October 24, 2018
Michael Flaherty, M.D., discusses a study published in Circulation Research which finds that use of hemodynamic suppo
Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
Overlay Init